Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bachmann

Showing results (211-220 of 537) with videos related to

Pageof 54
Sort By:
Journal of Drug Targeting|February 1, 2022
Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancerHong Im Kim, Chad R Schultz, Gadisetti V R Chandramouli, et al.
Anaesthesia, Critical Care & Pain Medicine|May 12, 2019
Genetic contribution to PONV riskStefanie Klenke, Gudrun J de Vries, Laura Schiefer, et al.
American Journal of Physiology. Renal Physiology|July 14, 2012
Annexin A1 modulates macula densa function by inhibiting cyclooxygenase 2S Seidel, H Neymeyer, T Kahl, et al.
International Journal of Oncology|February 27, 2013
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastomaDana-Lynn T Koomoa, Dirk Geerts, Ingo Lange, et al.
BMC Cancer|August 11, 2016
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancerJ D Kuhlmann, A Bankfalvi, K W Schmid, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1995
Cellular distribution of angiotensin-converting enzyme after myocardial infarctionM Falkenhahn, F Franke, R M Bohle, et al.
Circulation Research|September 2, 2000
Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cellsC Willam, P Koehne, J S Jürgensen, et al.
Biochimie|January 1, 1995
Interactions of poly(ADP-ribose) with nuclear proteinsF R Althaus, S Bachmann, L Höfferer, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivityJérôme Clerc, Nan Li, Daniel Krahn, et al.
Leukemia Research|November 29, 2019
Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivoMarquicia R Pierce, Reeder M Robinson, Tannya R Ibarra-Rivera, et al.
Pageof 54

Showing results (211-220 of 537) with videos related to

Sort By:
Pageof 54
Journal of Drug Targeting|February 1, 2022
Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancerHong Im Kim, Chad R Schultz, Gadisetti V R Chandramouli, et al.
Anaesthesia, Critical Care & Pain Medicine|May 12, 2019
Genetic contribution to PONV riskStefanie Klenke, Gudrun J de Vries, Laura Schiefer, et al.
American Journal of Physiology. Renal Physiology|July 14, 2012
Annexin A1 modulates macula densa function by inhibiting cyclooxygenase 2S Seidel, H Neymeyer, T Kahl, et al.
International Journal of Oncology|February 27, 2013
DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastomaDana-Lynn T Koomoa, Dirk Geerts, Ingo Lange, et al.
BMC Cancer|August 11, 2016
Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancerJ D Kuhlmann, A Bankfalvi, K W Schmid, et al.
Hypertension (Dallas, Tex. : 1979)|February 1, 1995
Cellular distribution of angiotensin-converting enzyme after myocardial infarctionM Falkenhahn, F Franke, R M Bohle, et al.
Circulation Research|September 2, 2000
Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cellsC Willam, P Koehne, J S Jürgensen, et al.
Biochimie|January 1, 1995
Interactions of poly(ADP-ribose) with nuclear proteinsF R Althaus, S Bachmann, L Höfferer, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
The natural product hybrid of Syringolin A and Glidobactin A synergizes proteasome inhibition potency with subsite selectivityJérôme Clerc, Nan Li, Daniel Krahn, et al.
Leukemia Research|November 29, 2019
Syrbactin proteasome inhibitor TIR-199 overcomes bortezomib chemoresistance and inhibits multiple myeloma tumor growth in vivoMarquicia R Pierce, Reeder M Robinson, Tannya R Ibarra-Rivera, et al.
Pageof 54